193 results on '"Alou L"'
Search Results
2. Correction: Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model
3. Exposure–response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria
4. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1–2 μg/mL
5. COLONIC BACTERIAL TRANSLOCATION IS INVOLVED IN THE NEUROINFLAMMATION DETECTED IN A DEPRESSION-LIKE MODEL THROUGH ACTIVATION OF MAPK PATHWAYS: 46
6. Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity
7. Efficacy of intraoperative antiseptic scrub after nail removal surgery
8. β-lactam antibiotics increase complement mediated immunity and enhances bacterial clearance of antibiotic-resistant pneumococcal strains: P13-52
9. Activity of serum concentrations of daptomycin vs. vancomycin against vancomycin-susceptible and resistant Enterococcus faecium in the presence of albumin physiological concentrations: an in vitro pharmacodynamic simulation
10. Impact of sunlight exposure on the residual efficacy of biolarvicides Bacillus thuringiensis israelensis and Bacillus sphaericus against the main malaria vector, Anopheles gambiae
11. Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin-resistant Streptococcus pneumoniae
12. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives
13. Are β-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
14. In Vitro Susceptibility to Gemifloxacin and Trovafloxacin of Streptococcus pneumoniae Strains Exhibiting Decreased Susceptibility to Ciprofloxacin
15. Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones
16. Mapping insecticide resistance in Anopheles gambiae (s.l.) from Côte d'Ivoire
17. Efficacy of Interceptor (R) G2, a new long-lasting insecticidal net against wild pyrethroid-resistant Anopheles gambiae s.s. from Cote d'Ivoire : a semi-field trial
18. Dynamics of malaria transmission, prevalence and incidence rates in Korhogo area, northern Cote d'Ivoire
19. Efficacy of Olyset (R) Duo, a permethrin and pyriproxyfen mixture net against wild pyrethroid-resistant Anopheles gambiae s.s. from Cote d'Ivoire : an experimental hut trial
20. Re-visiting insecticide resistance status in Anopheles gambiae from Cote d'Ivoire : a nation-wide informative survey
21. Update on resistance status of Anopheles gambiae s.s. to conventional insecticides at a previous WHOPES field site, 'Yaokoffikro', 6 years after the political crisis in Cote d'Ivoire
22. Distribution of ace-1(R) and resistance to carbamates and organophosphates in Anopheles gambiae s.s. populations from Cote d'Ivoire
23. Genotypic versus Phenotypic Characterization, with Respect to beta-Lactam Susceptibility, of Haemophilus influenzae Isolates Exhibiting Decreased Susceptibility to beta-Lactam Resistance Markers
24. In vitro interference of β-lactams with biofilm development by prevalent community respiratory tract isolates
25. No habitat preference in mixed meadows and rocky bottoms for Mediterranean Labridae and Sparidae fish species
26. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients
27. In vitro interference of tigecycline at subinhibitory concentrations on biofilm development by Enterococcus faecalis
28. Ausencia de predilección en lábridos y espáridos mediterráneos respecto a dos tipos de hábitat: fondos rocosos y fondos mixtos de praderas de fanerógamas marinas y roca
29. Evolving architectural patterns in microbial colonies development
30. Influence of Media and Testing Methodology on Susceptibility to Tigecycline of Enterobacteriaceae with Reported High Tigecycline MIC
31. In Vitro Killing Activity of Crevicular Concentrations of Tinidazole Plus Common Oral Antibiotics Against High-Density Mixed Inocula of Periodontal Pathogens in Strict Anaerobic Conditions
32. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline
33. Tinidazole inhibitory and cidal activity against anaerobic periodontal pathogens
34. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different -lactams: an in vitro pharmacodynamic approach
35. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness
36. β-Lactam Activity against Penicillin-Resistant Streptococcus pneumoniae Strains Exhibiting Higher Amoxicillin versus Penicillin Minimum Inhibitory Concentration Values: An in vitro Pharmacodynamic Simulation
37. Levofloxacin vs. Azithromycin Pharmacodynamic Activity AgainstS. pneumoniaeandH. influenzaewith Decreased Susceptibility to Amoxicillin/Clavulanic Acid
38. Influence of TEM-1 β-Lactamase on the Pharmacodynamic Activity of Simulated Total versus Free-Drug Serum Concentrations of Cefditoren (400 Milligrams) versus Amoxicillin-Clavulanic Acid (2,000/125 Milligrams) against Haemophilus influenzae Strains Exhibiting an N526K Mutation in the ftsI Gene
39. Pharmacodynamics of Simulated Total Versus Free-Drug Serum Concentrations of a Low Versus a High Protein Bound Third-Generation Oral Cephalosporin (Cefpodoxime Versus Cefditoren) AgainstStreptococcus pneumoniae
40. P2061 Bactericidal activity of simulated serum concentrations of bid regimens of 400 mg cefditoren and 2000/125 mg amox-icillin/clavunanic acid against ampicillin susceptible and resistant H. infiuenzae: an in vitro pharmacodynamic model
41. P2059 Effect of human albumin physiological concentrations on the in vitro bactericidal activity of daptomycin vs. vancomycin Cmax concentrations against Gram-positive isolates exhibiting the main resistance phenotypes
42. P2060 Effects of cefditoren, cefuroxime, cefaclor and cefixime on the competitive growth of Streptococcus pneumoniae, as a model approach to selection of populations
43. P2063 Dose ranging and fractionation of moxifioxacin against Stenotrophomonas maltophilia using an in vitro pharmacodynamic model
44. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia
45. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae
46. Increase of in vitro amoxycillin bactericidal activity by clavulanic acid against Neisseria meningitis using time-kill curves
47. Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers
48. Evaluation of two in vitro pharmacodynamic simulation models: microfiltration versus centrifugation–filtration
49. Efficacy of trovafloxacin in an in vitro pharmacodynamic simulation of an intraabdominal infection
50. Evolving architectural patterns in microbial colonies development.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.